Region: Europe

We should fight it out with Ericsson in Texas, Apple tells the ITC

Case filed yesterday by the iPhone giant makes clear that it wants its patent licensing dispute with the Swedish company to centre on the US court system

20 January 2022

Turkish court issues preliminary injunction to prevent infringement of pharmaceutical products

Currently, the Turkish Medicines and Medical Devices Agency does not investigate whether drugs supplied from abroad infringe patent rights. However, a recent case provides useful guidance for the steps to be taken, where such infringement occurs.

19 January 2022

The EPO and UKIPO approaches to AI and patentable subject matter

Co-published - Although the UK is a member of the European Patent Organisation, there are ways in which the two agencies differ in how they look at granting protection in the field

18 January 2022

Ericsson sues Apple for patent infringement as cross-licence deal expires

Swedish telco asserts patents against the iPhone maker in the Western District of Texas and at least one jurisdiction outside the US

18 January 2022

Landmark Dusseldorf non-FRAND finding is big news for joint licensing programmes

SEP licensors will have to look again at duplicate royalty reimbursement policies following first-of-a-kind ruling

13 January 2022

Unitary patent promises a cheaper alternative for life sciences companies

The new unitary patent system is finally due to come into effect this year and looks sets to be more cost-effective for life sciences innovators. However, conventional national validation may still be necessary for full coverage.

12 January 2022

Vaccine patent rights - a scapegoat for inequality?

The unequal dissemination of covid-19 vaccines remains controversial, yet while a proposed IP rights waiver might enhance global access to affordable vaccines, it remains unlikely that it would provide a solution to the unequal rollout.

12 January 2022

IP Court clarifies what constitutes token use for trademarks vulnerable to non-use

Russian owners may claim token use to prevent their trademarks being cancelled. However, whether this will be regarded as sufficient evidence of use depends on market conditions and business practices.

12 January 2022

Supreme Court dispels doubts about statute of limitations for claims arising from industrial property infringements

A fresh ruling involving the systematic infringement of an EU trademark appears to have ended the debate on continuous infringement in Poland – and could also have big implications for patent holders.

12 January 2022

The EU’s patent attorney deficit is a major hindrance to innovation leadership

A new scheme launched yesterday offers finding to SMEs seeking to protect their inventions but does little to tackle what is a major problem in many member states

11 January 2022

Get unlimited access to all IAM content